Skip to main content
. 2021 Dec 14;12:781797. doi: 10.3389/fmicb.2021.781797

TABLE 1.

Characteristics of the patients in the total group and the clusters based on airway microbiota.

Total Cluster 1 Cluster 2 Cluster 3 p-value
Cluster 1 vs. 3 Cluster 1 vs. 2 Cluster 2 vs. 3
Number 38 7 20 11
Male 24 (63.2%) 2 (28.6%) 16 (80.0%) 6 (54.5%) 0.280 0.013 0.135
Age, years 60.9 ± 9.4 61.4 ± 11.5 59.2 ± 9.2 63.5 ± 8.5 0.659 0.609 0.205
BMI, kg/m2 26.0 ± 6.2 22.2 ± 4.1 27.4 ± 6.5 25.9 ± 6.1 0.182 0.063 0.544
Smoking history
Former 25 (65.8%) 5 (71.4%) 12 (60.0%) 8 (72.7%) 0.952 0.590 0.479
Pack-years 47.3 ± 18.4 54.9 ± 31.5 45.1 ± 10.8 46.5 ± 19.5 0.492 0.2287 0.797
Exacerbations in the last year
Number of patients 26 (68.4%) 5 (71.4%) 14 (70.0%) 7 (63.6%) 0.724 0.943 0.717
Number of episodes per patient 2.4 ± 1.4 2.8 ± 1.6 2.3 ± 1.1 2.4 ± 1.8 0.732 0.450 0.826
Symptoms
Cough 29 (76.3%) 7 (100%) 16 (80.0%) 6 (54.5%) 0.036 0.264 0.077
Dyspnea ≥2 mMRC 31 (81.5%) 7 (100%) 15 (75.0%) 9 (81.8%) 0.497 0.283 1
Chronic bronchitis 18 (47.4%) 5 (71.4%) 8 (40.0%) 5 (45.5%) 0.280 0.152 0.768
CAT total score 19.0 ± 7.8 23.8 ± 4.6 18.2 ± 7.6 17.8 ± 9.3 0.204 0.134 0.895
Lung function
FEV1, % pred 45.5 ± 19.5 48.2 ± 8.1 51.8 ± 21.9 46.7 ± 19.0 0.797 0.726 0.549
FEV1/FVC 47.6 ± 12.0 46.0 ± 5.7 49.8 ± 11.3 47.8 ± 13.5 0.621 0.490 0.695
RV, % pred 215.7 ± 90.5 243.3 ± 60.1 213.9 ± 104.8 201.0 ± 85.5 0.273 0.497 0.736
GOLD 3-4 22 (57.9%) 6 (85.7%) 10 (50.0%) 7 (63.6%) 0.596 0.183 0.707
6-min walking distance, n 32 7 16 9
Distance, % of predicted value 66.4 ± 22.6 69.3 ± 16.6 68.8 ± 26.6 60.1 ± 19.8 0.341 0.945 0.466
CT scan, n 35 7 19 9
Emphysema, n 29 (82.9%) 7 (100%) 14 (73.7%) 8 (88.9%) 0.362 0.131 0.36
Emphysema visual score 9.2 ± 4.7 7.0 ± 2.4 10.4 ± 5.3 9.1 ± 4.6 0.299 0.124 0.570
Questionnaires, n 37 7 20 10
CASA-Q
Cough symptoms 64.2 ± 21.7 51.2 ± 32.8 63.7 ± 16.3 74.2 ± 19.0 0.087 0.194 0.129
Sputum symptoms 58.8 ± 24.1 53.6 ± 32.2 52.9 ± 21.0 74.2 ± 18.6 0.115 0.951 0.011
Cough impact 70.1 ± 24.1 50.0 ± 18.0 70.5 ± 22.2 83.4 ± 23.6 0.007 0.038 0.151
Sputum impact 74.2 ± 29.9 58.3 ± 22.7 73.5 ± 19.01 86.7 ± 16.5 0.009 0.095 0.074
HAD
Anxiety score 8.4 ± 4.5 12.2 ± 4.4 8.2 ± 4.0 6.6 ± 4.7 0.034 0.044 0.348
Depression score 6.6 ± 3.9 6.5 ± 3.3 6.7 ± 4.6 6.5 ± 2.8 1 0.941 0.925
SGRQ
Total 52.9 ± 19.0 57.6 ± 14.9 52.4 ± 20.6 50.7 ± 19.3 0.440 0.548 0.826
SF-36
Global physical health 33.5 ± 10.4 35.2 ± 12.4 33.1 ± 9.0 33.1 ± 12.6 0.742 0.633 0.992
Global mental health 31.3 ± 18.2 15.6 ± 19.2 33.4 ± 17.7 37.9 ± 13.0 0.012 0.034 0.485

Unless otherwise stated, data are available for all patients. Indicated in bold are the characteristics that are statistically significant between clusters 1 and 3 (chi-square test, Fisher exact test, t-test, and Mann–Whitney test).

BMI, body mass index; mMRC, modified Medical Research Council dyspnea scale; FEV, forced expiratory volume in 1 s; FVC, forced vital capacity; RV, residual volume; CASA-Q, Cough and Sputum Assessment Questionnaire; HAD, Hospital Anxiety and Depression Scale; SGRQ, St. George’s Respiratory Questionnaire; SF-36, 36-item short-form health survey.